{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T08:24:54Z","timestamp":1777710294263,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["20160101122JC"],"award-info":[{"award-number":["20160101122JC"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11255-019-02074-9","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T09:26:22Z","timestamp":1549617982000},"page":"755-764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes"],"prefix":"10.1007","volume":"51","author":[{"given":"Dan","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-ting","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-shi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-yu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"issue":"1","key":"2074_CR1","doi-asserted-by":"publisher","first-page":"e0147329","DOI":"10.1371\/journal.pone.0147329","volume":"11","author":"M Narres","year":"2016","unstructured":"Narres M, Claessen H, Droste S, Kvitkina T, Koch M, Kuss O, Icks A (2016) The incidence of end-stage renal disease in the diabetic (compared to the non-diabetic) population: a systematic review. PLoS ONE 11(1):e0147329. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0147329","journal-title":"PLoS ONE"},{"issue":"1","key":"2074_CR2","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1530\/JOE-14-0437","volume":"224","author":"Y Ding","year":"2015","unstructured":"Ding Y, Choi ME (2015) Autophagy in diabetic nephropathy. J Endocrinol 224(1):R15\u2013R30. \n                    https:\/\/doi.org\/10.1530\/JOE-14-0437","journal-title":"J Endocrinol"},{"key":"2074_CR3","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7255.1","author":"J Reiser","year":"2016","unstructured":"Reiser J, Altintas MM (2016) Podocytes. F1000Research. \n                    https:\/\/doi.org\/10.12688\/f1000research.7255.1","journal-title":"F1000Research"},{"issue":"4","key":"2074_CR4","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/74166","volume":"24","author":"N Boute","year":"2000","unstructured":"Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24(4):349\u2013354. \n                    https:\/\/doi.org\/10.1038\/74166","journal-title":"Nat Genet"},{"key":"2074_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008813","author":"G Das","year":"2012","unstructured":"Das G, Shravage BV, Baehrecke EH (2012) Regulation and function of autophagy during cell survival and cell death. Cold Spring Harb Perspect Biol. \n                    https:\/\/doi.org\/10.1101\/cshperspect.a008813","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"2074_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cmet.2008.08.009","volume":"8","author":"C Ebato","year":"2008","unstructured":"Ebato C, Uchida T, Arakawa M, Komatsu M, Ueno T, Komiya K, Azuma K, Hirose T, Tanaka K, Kominami E, Kawamori R, Fujitani Y, Watada H (2008) Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab 8(4):325\u2013332. \n                    https:\/\/doi.org\/10.1016\/j.cmet.2008.08.009","journal-title":"Cell Metab"},{"issue":"6009","key":"2074_CR7","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1126\/science.1193497","volume":"330","author":"JD Rabinowitz","year":"2010","unstructured":"Rabinowitz JD, White E (2010) Autophagy and metabolism. Science 330(6009):1344\u20131348. \n                    https:\/\/doi.org\/10.1126\/science.1193497","journal-title":"Science"},{"issue":"7","key":"2074_CR8","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4161\/auto.7.7.15371","volume":"7","author":"J Ezaki","year":"2011","unstructured":"Ezaki J, Matsumoto N, Takeda-Ezaki M, Komatsu M, Takahashi K, Hiraoka Y, Taka H, Fujimura T, Takehana K, Yoshida M, Iwata J, Tanida I, Furuya N, Zheng DM, Tada N, Tanaka K, Kominami E, Ueno T (2011) Liver autophagy contributes to the maintenance of blood glucose and amino acid levels. Autophagy 7(7):727\u2013736","journal-title":"Autophagy"},{"issue":"12","key":"2074_CR9","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1080\/15548627.2015.1115173","volume":"11","author":"M Yasuda-Yamahara","year":"2015","unstructured":"Yasuda-Yamahara M, Kume S, Tagawa A, Maegawa H, Uzu T (2015) Emerging role of podocyte autophagy in the progression of diabetic nephropathy. Autophagy 11(12):2385\u20132386. \n                    https:\/\/doi.org\/10.1080\/15548627.2015.1115173","journal-title":"Autophagy"},{"issue":"3","key":"2074_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1470320310369603","volume":"11","author":"S Lin","year":"2010","unstructured":"Lin S, Li D, Jia J, Zheng Z, Jia Z, Shang W (2010) Spironolactone ameliorates podocytic adhesive capacity via restoring integrin alpha 3 expression in streptozotocin-induced diabetic rats. J Renin Angiotensin Aldosterone Syst 11(3):149\u2013157. \n                    https:\/\/doi.org\/10.1177\/1470320310369603","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"12","key":"2074_CR11","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1681\/ASN.2009070737","volume":"20","author":"UF Mehdi","year":"2009","unstructured":"Mehdi UF, Adams-Huet B, Raskin P, Vega GL, Toto RD (2009) Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. J Am Soc Nephrol 20(12):2641\u20132650. \n                    https:\/\/doi.org\/10.1681\/ASN.2009070737","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2074_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/jdi.12235","volume":"5","author":"S Skovso","year":"2014","unstructured":"Skovso S (2014) Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabet Investig 5(4):349\u2013358. \n                    https:\/\/doi.org\/10.1111\/jdi.12235","journal-title":"J Diabet Investig"},{"issue":"9","key":"2074_CR13","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1681\/ASN.2014080819","volume":"26","author":"L Dong","year":"2015","unstructured":"Dong L, Pietsch S, Tan Z, Perner B, Sierig R, Kruspe D, Groth M, Witzgall R, Grone HJ, Platzer M, Englert C (2015) Integration of cistromic and transcriptomic analyses identifies Nphs2, Mafb, and Magi2 as Wilms\u2019 tumor 1 target genes in podocyte differentiation and maintenance. J Am Soc Nephrol 26(9):2118\u20132128. \n                    https:\/\/doi.org\/10.1681\/ASN.2014080819","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2074_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/his.12002","volume":"62","author":"J Choi","year":"2013","unstructured":"Choi J, Jung W, Koo JS (2013) Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer. Histopathology 62(2):275\u2013286. \n                    https:\/\/doi.org\/10.1111\/his.12002","journal-title":"Histopathology"},{"issue":"4","key":"2074_CR15","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Komatsu M (2011) Autophagy: renovation of cells and tissues. Cell 147(4):728\u2013741. \n                    https:\/\/doi.org\/10.1016\/j.cell.2011.10.026","journal-title":"Cell"},{"issue":"6","key":"2074_CR16","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1111\/j.1523-1755.2005.00727.x","volume":"68","author":"RS Danda","year":"2005","unstructured":"Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, Pergola PE (2005) Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int 68(6):2562\u20132571. \n                    https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00727.x","journal-title":"Kidney Int"},{"issue":"7","key":"2074_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.4161\/auto.19821","volume":"8","author":"TB Huber","year":"2012","unstructured":"Huber TB, Edelstein CL, Hartleben B, Inoki K, Jiang M, Koya D, Kume S, Lieberthal W, Pallet N, Quiroga A, Ravichandran K, Susztak K, Yoshida S, Dong Z (2012) Emerging role of autophagy in kidney function, diseases and aging. Autophagy 8(7):1009\u20131031. \n                    https:\/\/doi.org\/10.4161\/auto.19821","journal-title":"Autophagy"},{"issue":"3","key":"2074_CR18","doi-asserted-by":"publisher","first-page":"F380","DOI":"10.1152\/ajprenal.00502.2010","volume":"302","author":"M Takagi-Akiba","year":"2012","unstructured":"Takagi-Akiba M, Asanuma K, Tanida I, Tada N, Trejo JA, Nonaka K, Asanuma E, Kominami E, Ueno T, Tomino Y (2012) Doxorubicin-induced glomerulosclerosis with proteinuria in GFP-GABARAP transgenic mice. Am J Physiol Renal Physiol 302(3):F380\u2013F389","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2074_CR19","doi-asserted-by":"publisher","first-page":"F380","DOI":"10.1152\/ajprenal.00502.2010","volume":"302","author":"M Takagi-Akiba","year":"2012","unstructured":"Takagi-Akiba M, Asanuma K, Tanida I, Tada N, Oliva Trejo JA, Nonaka K, Asanuma E, Kominami E, Ueno T, Tomino Y (2012) Doxorubicin-induced glomerulosclerosis with proteinuria in GFP-GABARAP transgenic mice. Am J Physiol Renal Physiol 302(3):F380\u2013F389. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00502.2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"2074_CR20","doi-asserted-by":"publisher","first-page":"F74","DOI":"10.1152\/ajprenal.00114.2017","volume":"313","author":"M Yi","year":"2017","unstructured":"Yi M, Zhang L, Liu Y, Livingston MJ, Chen JK, Nahman NS Jr, Liu F, Dong Z (2017) Autophagy is activated to protect against podocyte injury in adriamycin-induced nephropathy. Am J Physiol Renal Physiol 313(1):F74\u2013F84. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00114.2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"2074_CR21","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/15548627.2015.1135284","volume":"12","author":"A Melk","year":"2016","unstructured":"Melk A, Baisantry A, Schmitt R (2016) The yin and yang of autophagy in acute kidney injury. Autophagy 12(3):596\u2013597. \n                    https:\/\/doi.org\/10.1080\/15548627.2015.1135284","journal-title":"Autophagy"},{"issue":"3","key":"2074_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2337\/db15-0473","volume":"65","author":"A Tagawa","year":"2016","unstructured":"Tagawa A, Yasuda M, Kume S, Yamahara K, Nakazawa J, Chin-Kanasaki M, Araki H, Araki S, Koya D, Asanuma K, Kim EH, Haneda M, Kajiwara N, Hayashi K, Ohashi H, Ugi S, Maegawa H, Uzu T (2016) Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy. Diabetes 65(3):755\u2013767. \n                    https:\/\/doi.org\/10.2337\/db15-0473","journal-title":"Diabetes"},{"issue":"6","key":"2074_CR23","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1111\/j.1523-1755.2005.00756.x","volume":"68","author":"KJ Schjoedt","year":"2005","unstructured":"Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Rossing P, Tarnow L, Parving HH (2005) Beneficial impact of spironolactone in diabetic nephropathy. Kidney Int 68(6):2829\u20132836. \n                    https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00756.x","journal-title":"Kidney Int"},{"issue":"5","key":"2074_CR24","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1681\/ASN.2005111196","volume":"17","author":"SY Han","year":"2006","unstructured":"Han SY, Kim CH, Kim HS, Jee YH, Song HK, Lee MH, Han KH, Kim HK, Kang YS, Han JY, Kim YS, Cha DR (2006) Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats. J Am Soc Nephrol 17(5):1362\u20131372. \n                    https:\/\/doi.org\/10.1681\/ASN.2005111196","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2074_CR25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MNH.0000000000000340","volume":"26","author":"FK Dojki","year":"2017","unstructured":"Dojki FK, Bakris G (2017) Nonsteroidal mineralocorticoid antagonists in diabetic kidney disease. Curr Opin Nephrol Hypertens 26(5):368\u2013374. \n                    https:\/\/doi.org\/10.1097\/MNH.0000000000000340","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"2074_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/MNH.0000000000000290","volume":"26","author":"OA Dhaybi","year":"2017","unstructured":"Dhaybi OA, Bakris G (2017) Mineralocorticoid antagonists in chronic kidney disease. Curr Opin Nephrol Hypertens 26(1):50\u201355. \n                    https:\/\/doi.org\/10.1097\/MNH.0000000000000290","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"2074_CR27","doi-asserted-by":"publisher","first-page":"e12148","DOI":"10.5812\/numonthly.12148","volume":"6","author":"A Makhlough","year":"2014","unstructured":"Makhlough A, Kashi Z, Akha O, Zaboli E, Yazdanicharati J (2014) Effect of spironolactone on diabetic nephropathy compared to the combination of spironolactone and losartan. Nephro-Urol Monthly 6(1):e12148. \n                    https:\/\/doi.org\/10.5812\/numonthly.12148","journal-title":"Nephro-Urol Monthly"},{"issue":"6","key":"2074_CR28","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s10157-015-1106-2","volume":"19","author":"S Kato","year":"2015","unstructured":"Kato S, Maruyama S, Makino H, Wada J, Ogawa D, Uzu T, Araki H, Koya D, Kanasaki K, Oiso Y, Goto M, Nishiyama A, Kobori H, Imai E, Ando M, Matsuo S (2015) Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial. Clin Exp Nephrol 19(6):1098\u20131106. \n                    https:\/\/doi.org\/10.1007\/s10157-015-1106-2","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"2074_CR29","doi-asserted-by":"publisher","first-page":"6849","DOI":"10.3892\/mmr.2015.4295","volume":"12","author":"Z Li","year":"2015","unstructured":"Li Z, Zhang L, Shi W, Chen Y, Zhang H, Liu S, Liang X, Ling T, Yu C, Huang Z, Tan X, Zhao X, Ye Z, Zhang B, Wang W, Li R, Ma J (2015) Spironolactone inhibits podocyte motility via decreasing integrin beta1 and increasing integrin beta3 in podocytes under high-glucose conditions. Mol Med Rep 12(5):6849\u20136854. \n                    https:\/\/doi.org\/10.3892\/mmr.2015.4295","journal-title":"Mol Med Rep"},{"key":"2074_CR30","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20160086","author":"D Li","year":"2016","unstructured":"Li D, Lu Z, Xu Z, Ji J, Zheng Z, Lin S, Yan T (2016) Spironolactone promotes autophagy via inhibiting PI3K\/AKT\/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress. Biosci Rep. \n                    https:\/\/doi.org\/10.1042\/BSR20160086","journal-title":"Biosci Rep"},{"key":"2074_CR31","doi-asserted-by":"publisher","first-page":"3560238","DOI":"10.1155\/2017\/3560238","volume":"2017","author":"N Liu","year":"2017","unstructured":"Liu N, Xu L, Shi Y, Zhuang S (2017) Podocyte autophagy: a potential therapeutic target to prevent the progression of diabetic nephropathy. J Diabet Res 2017:3560238. \n                    https:\/\/doi.org\/10.1155\/2017\/3560238","journal-title":"J Diabet Res"},{"issue":"8","key":"2074_CR32","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1093\/ndt\/gfq750","volume":"26","author":"J Toyonaga","year":"2011","unstructured":"Toyonaga J, Tsuruya K, Ikeda H, Noguchi H, Yotsueda H, Fujisaki K, Hirakawa M, Taniguchi M, Masutani K, Iida M (2011) Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production. Nephrol Dial Transplant 26(8):2475\u20132484. \n                    https:\/\/doi.org\/10.1093\/ndt\/gfq750","journal-title":"Nephrol Dial Transplant"},{"key":"2074_CR33","doi-asserted-by":"publisher","first-page":"917","DOI":"10.5604\/17322693.1218180","volume":"70","author":"M Chaszczewska-Markowska","year":"2016","unstructured":"Chaszczewska-Markowska M, Sagan M, Bogunia-Kubik K (2016) The renin-angiotensin-aldosterone system (RAAS)\u2014physiology and molecular mechanisms of functioning. Postepy Hig Med Dosw 70:917\u2013927. \n                    https:\/\/doi.org\/10.5604\/17322693.1218180","journal-title":"Postepy Hig Med Dosw"},{"issue":"2","key":"2074_CR34","doi-asserted-by":"publisher","first-page":"C488","DOI":"10.1152\/ajpcell.00424.2009","volume":"299","author":"A Yadav","year":"2010","unstructured":"Yadav A, Vallabu S, Arora S, Tandon P, Slahan D, Teichberg S, Singhal PC (2010) ANG II promotes autophagy in podocytes. Am J Physiol Cell Physiol 299(2):C488\u2013C496. \n                    https:\/\/doi.org\/10.1152\/ajpcell.00424.2009","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"2074_CR35","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00004872-199305000-00001","volume":"11","author":"F Soubrier","year":"1993","unstructured":"Soubrier F, Hubert C, Testut P, Nadaud S, Alhenc-Gelas F, Corvol P (1993) Molecular biology of the angiotensin I converting enzyme: I. Biochemistry and structure of the gene. J Hypertens 11(5):471\u2013476","journal-title":"J Hypertens"},{"issue":"5","key":"2074_CR36","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S (2000) A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circ Res 87(5):E1\u2013E9","journal-title":"Circ Res"},{"issue":"Pt 1","key":"2074_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/BJ20040634","volume":"383","author":"GI Rice","year":"2004","unstructured":"Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM (2004) Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383(Pt 1):45\u201351. \n                    https:\/\/doi.org\/10.1042\/BJ20040634","journal-title":"Biochem J"},{"issue":"6","key":"2074_CR38","doi-asserted-by":"publisher","first-page":"F1264","DOI":"10.1152\/ajprenal.00183.2017","volume":"313","author":"A Zimnol","year":"2017","unstructured":"Zimnol A, Amann K, Mandel P, Hartmann C, Schupp N (2017) Angiotensin II type 1a receptor-deficient mice develop angiotensin II-induced oxidative stress and DNA damage without blood pressure increase. Am J Physiol Renal Physiol 313(6):F1264\u2013F1273. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00183.2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"2074_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","volume":"65","author":"J Bauersachs","year":"2015","unstructured":"Bauersachs J, Jaisser F, Toto R (2015) Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases. Hypertension 65(2):257\u2013263. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.04488","journal-title":"Hypertension"},{"issue":"6","key":"2074_CR40","doi-asserted-by":"publisher","first-page":"900","DOI":"10.5301\/jn.5000134","volume":"25","author":"L Tylicki","year":"2012","unstructured":"Tylicki L, Lizakowski S, Rutkowski B (2012) Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions. J Nephrol 25(6):900\u2013910. \n                    https:\/\/doi.org\/10.5301\/jn.5000134","journal-title":"J Nephrol"},{"issue":"9 Pt 1","key":"2074_CR41","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0895-7061(03)00913-0","volume":"16","author":"A Sato","year":"2003","unstructured":"Sato A, Saruta T (2003) Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy. Am J Hypertens 16(9 Pt 1):781\u2013788","journal-title":"Am J Hypertens"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-019-02074-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-019-02074-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-019-02074-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T19:14:35Z","timestamp":1581102875000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-019-02074-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2074"],"URL":"https:\/\/doi.org\/10.1007\/s11255-019-02074-9","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,8]]},"assertion":[{"value":"25 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of Jilin University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}